Evidence map›Paper›PMID 35627110›Full record

ArticleGenes2022

Severe Infantile Axonal Neuropathy with Respiratory Failure Caused by Novel Mutation in X-Linked

Agnieszka Stembalska, Małgorzata Rydzanicz, Wojciech Walas, Piotr Gasperowicz, Agnieszka Pollak, Victor Murcia Pienkowski, Mateusz Biela, Magdalena Klaniewska, Zuzanna Gamrot, Ewa Gronska and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. A NovelGenes · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Agnieszka StembalskaDepartment of Genetics, Medical University, 50-368 Wroclaw, Poland.
Małgorzata RydzaniczDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.ORCID 0000-0002-6969-0535
Wojciech WalasPaediatric and Neonatal Intensive Care Unit, University Hospital in Opole, 45-401 Opole, Poland.
Piotr GasperowiczDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.ORCID 0000-0002-1037-7974
Agnieszka PollakDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.
Victor Murcia PienkowskiDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.
Mateusz BielaDepartment of Family and Paediatric Nursing, Medical University, 50-996 Wroclaw, Poland.ORCID 0000-0002-3461-193X
Magdalena KlaniewskaDepartment of Family and Paediatric Nursing, Medical University, 50-996 Wroclaw, Poland.ORCID 0000-0001-5738-8526
Zuzanna GamrotCare and Therapy Unit for Mechanically Ventilated Children and Young People, 41-506 Chorzow, Poland.
Ewa GronskaCare and Therapy Unit for Mechanically Ventilated Children and Young People, 41-506 Chorzow, Poland.
Rafal PloskiDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.ORCID 0000-0001-6286-5526
Robert SmigielDepartment of Family and Paediatric Nursing, Medical University, 50-996 Wroclaw, Poland.
Medical University of Warsaw · PLWroclaw Medical University · PLAix-Marseille Université · FRUniversity of Opole · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LAS1L encodes a nucleolar ribosomal biogenesis protein and is also a component of the Five Friends of Methylated CHTOP (5FMC) complex. Mutations in the LAS1L gene can be associated with Wilson−Turner syndrome (WTS) and, much more rarely, severe infantile hypotonia with respiratory failure. Here, we present an eighteen-month old boy with a phenotype of spinal muscular atrophy with respiratory distress (SMARD). By applying WES, we identified a novel hemizygous synonymous variant in the LAS1L gene inherited from an unaffected mother (c.846G > C, p.Thr282=). We suggest that the identified variant impairs the RNA splicing process. Furthermore, we proved the absence of any coding regions by qPCR and sequencing cDNA using amplicon deep sequencing and Sanger sequencing methods. According to the SMARD phenotype, severe breathing problems causing respiratory insufficiency, hypotonia, and feeding difficulties were observed in our patient from the first days of life. Remarkably, our case is the second described patient with a SMARD-like phenotype due to a mutation in the LAS1L gene and the first with a variant impacting splicing.

Indexed as

Muscular Atrophy, SpinalRespiratory InsufficiencyHumansMuscle HypotoniaMutationNuclear ProteinsPolyneuropathiesRespiratory Distress Syndrome, NewbornNuclear Proteinsinfantile hypotoniaLAS1L generespiratory failure syndromeSMARD

Identifiers

PMID35627110
PMCPMC9142081
OpenAlexW4224285813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.